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We have carefully read the interesting review article by 
Wasilczuk and Korzeniewski, about immunocompromised 
travellers (ICTs) [1]. We agree on the fact, that if acquired, 
vector-borne diseases, such as chikungunya (CHIK) [2], may 
be more severe in ICTs. Also, on the fact that respiratory tract 
infections (RTIs) are one of the most common travel-related 
health problems. However, we would like to discuss recent 
data from our group showing that CHIK would represent 
a potential risk for the development of RTIs, possibly due 
to immunosuppression. 
From 2014 to 2016 we analysed and followed up 
11,518 patients from Hospital San Pedro y San Pablo, La 
Virginia, Colombia in order to detect CHIK infection and, 
later, to assess the occurrence of RTIs. During that pe-
riod, 364 patients were CHIK+ (serologically confirmed 
chikungunya infection and 11,154 were CHIK–, with a me-
dian follow-up of 20.2 months, that after its consultation 
developed any RTI (defined according the ICD-10 codes 
J00-J22 [acute upper and lower RTIs, including influen-
za and pneumonia]). Global and disease-specific relative 
risk (RRs) with its 95% confidence intervals (95% CIs) 
were calculated. HIV-positive patients were excluded from 
these analyses.
In CHIK+ patients, RR for any RTI was 1.117 (95% 
CI 1.001–1.247), when compared with those without 
CHIK. For acute laryngotracheitis (ALT), RR = 2.857 (95% 
CI 1.572–5.192); acute tracheitis, RR = 1.810 (95% CI 
1.359–2.409); acute maxillary sinusitis, RR = 1.750 (95% 
CI 1.270–2.412); acute laryngitis, RR = 1.707 (95% CI 
1.048–2.778); acute pharyngitis, RR = 1.667 (95% CI 
1.005–2.765); acute bronchiolitis, RR = 1.631 (95% CI 
1.544–1.722); streptococcal tonsillitis, RR = 1.288 (95% 
CI 1.149–1.443); acute bronchitis due to rhinovirus, 
RR = 1.217 (95% CI 1.024–1.447). From them, 20% de-
veloped RTIs at 9 months. Non-significant differences were 
observed for influenza and pneumonia. 
Although we did not assess specifically immune function in 
these patients, one study performed recently in Colombia [3] 
showed evidence that after CHIK infection (9 months lat-
er) CD4 T-lymphocytopaenia would be found (> 60% with 
< 300 CD4/mL), consistent with the risk of developing 
opportunistic and other related infections, as we found 
association with RTIs up to almost 3 times higher, when 
compared to controls. Most of the reports on the chronic 
consequences of CHIK have been focused on rheumatologi-
cal sequelae, such as chronic inflammatory rheumatism [4], 
but few studies have related CHIK to RTIs [5, 6]. 
Previous epidemiological studies in India, suggested 
that during CHIK outbreaks, RTIs, such as those caused 
by adenovirus, influenza and respiratory syncytial virus, 
would be increased and even coinfecting [5]. In addition, we 
analysed the trends for reporting cases of both conditions 
in Colombia during the same period (2013–2015), and 
we found significant associations between CHIK and ALT 
(Fig. 1), but also an increase in RTIs during the CHIK out-
break of 2014 (Fig. 1), similar to what was reported in 
India [5]. Although the presented association needs further 
studies, its implications should be considered by travel 
medicine practitioners and in general those providing care 
to patients with CHIK. 
As Wasilczuk and Korzeniewski stated [1], interventions 
and guidance should be adequate to each traveller’s  im-
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Figure 1. A. Variation in the report of chikungunya and acute laryngotracheitis (ALT) in Colombia during 2014 and 2015. B. Variation 
in the report of CHIK and respiratory tract infections in Colombia during 2013–2015
munocompromised state and their general health, including 
informing the patients about the risks associated with acute and 
chronic consequences of CHIK, which would comprise RTIs too.
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